Moxifloxacin Stulln Sine

Moxifloxacin, the active ingredient in Moxifloxacin Stulln Sine, is a fluoroquinolone presented as an ophthalmic solution for ocular use. It treats bacterial eye infections such as conjunctivitis and keratitis in both adults and children. GNH USA supplies Moxifloxacin Stulln Sine as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Moxifloxacin is a fluoroquinolone antibacterial used in ophthalmology to treat bacterial infections of the eye.

- Bacterial conjunctivitis: reduces bacterial load and accelerates symptom relief. - Bacterial keratitis: eradicates pathogenic bacteria and promotes corneal healing. - Post‑operative ocular prophylaxis: prevents infection after eye surgery.

Moxifloxacin may cause local and systemic adverse reactions when administered as eye drops.

Common Side Effects: - Stinging or burning sensation at the application site. - Ocular irritation or foreign‑body feeling. - Redness of the conjunctiva (hyperemia). - Temporary blurred vision. - Increased tear production. - Mild eyelid edema.

Serious or Rare Side Effects: - Allergic reaction including swelling, rash or anaphylaxis. - Corneal ulceration or perforation. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Tendon rupture or tendinopathy (systemic effect). - Severe vision loss. - Persistent intraocular inflammation.

Before using Moxifloxacin Stulln Sine, consider the following safety measures.

- Allergy assessment: avoid if known hypersensitivity to fluoroquinolones. - Contact lens wear: discontinue lenses during treatment to reduce irritation. - Corneal epithelial defect: use with caution and monitor healing. - Systemic absorption: be alert for tendon pain or swelling. - Pregnancy and lactation: prescribe only when clearly needed. - Store at room temperature: keep in original container, protect from light and moisture.

Moxifloxacin ophthalmic solution can interact with other medications; awareness helps prevent reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Systemic fluoroquinolones: concurrent use may increase risk of systemic toxicity. - Corticosteroid eye drops: may mask signs of infection and worsen outcomes. - QT‑prolonging drugs: combined use can heighten cardiac arrhythmia risk.

Moderate Interactions (Monitor Closely): - Other topical antibiotics: monitor for additive ocular irritation. - Anticholinergic eye drops: may affect tear film stability. - Metal‑containing ophthalmic preparations: can reduce drug absorption.